Inhibrx Biosciences Statistics
NASDAQ: INBXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
93.36-0.05 (-0.05%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Inhibrx Biosciences by the numbers
Inhibrx Biosciences has a market capitalization of $1.37 billion based on 14.72M shares outstanding. With trailing EPS of $-8.88, Inhibrx Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.9% below its 50-day average and 2.4% above its 200-day average.
Average daily trading volume is 293.01K shares, or about $27.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INBX valuation vs. peer median
| Metric | INBX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.37B | $1.29B | +6% |
| Avg. volume | 293.01K | 681.59K | -57% |
Peer median across 8 companies: COAG, TSHA, MAZE, REPL, IMCR, IMTX, VOR, MGTX.
Valuation
- Market cap
- $1.37B
- EPS (TTM)
- $-8.88
- Shares outstanding
- 14.72M
Price and trading
- Previous close
- 93.41
- Open
- 92.02
- Day range
- 90.66 – 96.71
- 52-week range
- 28.16 – 155.29
- 52-week change
- +178.69%
- 50-day moving average
- 102.46
- Beta
- —
- Volume
- 223.78K
- Average volume
- 293.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 1.37B
- Forward Pe
- -10.66
- Eps
- -8.88
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 155.29
- Week52 Low
- 28.16
- Avg Volume
- 293.01K
- Shares Outstanding
- 14.72M
- Ma50
- 102.46
- Ma200
- 91.19
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -39.88%
- Pct From52w Low
- 231.53%